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ABSTRACT 
 Information about the external world is conveyed by the nervous system via 
specialized sensory organs such as the vomeronasal organ (VNO). The VNO is crucial 
for pheromone detection and the regulation of social behavior in many mammals. Recent 
research has shown that purinergic signaling pathways in the VNO play a role in the 
chemosensory activity of the organ. There are two families of purinergic receptors that 
may be involved in this activity, P2X and P2Y. We hypothesized that the vomeronasal 
sensory neurons express both P2X and P2Y receptors which, when activated by ATP or 
other purine/pyrimidine nucleotides, work to maintain homeostasis and assist in signal 
transduction in the tissue. This hypothesis was partially addressed using reverse 
transcription polymerase chain reaction (RT-PCR), immunohistochemistry, and 
immunocytochemistry to determine where P2X receptors are expressed and if P2Y 
receptors are expressed in the mouse VNO. RT-PCR results suggested that there is gene 
expression of P2Y1, P2Y2, P2Y6, P2X1, and P2X3 receptors in the tissue. A selection of 
the more commonly expressed purinergic receptors explored with immunohistochemistry 
indicated that P2Y1, P2Y2, and P2X1 receptors are widely expressed throughout the 
VNO, including expression in the sensory and non-sensory epithelia. 
Immunocytochemistry results demonstrated expression of P2Y1 and P2Y2 receptors on 
the vomeronasal sensory neurons, further supporting our hypothesis that the purinergic 
receptors play a role in signal transduction. In conclusion, our data strongly support the 
hypothesis that there are purinergic receptors present in the VNO of mice and are in 
agreement with our previous data showing purinergic receptor-mediated modulation of 
chemosensory signal transduction in vomeronasal sensory neurons.  
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INTRODUCTION 
Pheromone Signaling and the Vomeronasal Organ 
Pheromones are a powerful and ubiquitous form of communication and molecular 
control among species spanning every animal phylum, including single-cell organisms. 
They are commonly defined as secreted or excreted chemical signals that trigger a 
behavioral response in another member of the same species (Karlson and Luscher, 1959). 
Recent research suggests that pheromones also induce endocrine responses, and ongoing 
study will continue to determine the extent of the impact of pheromone signaling (Dulac 
and Torello, 2003). Extensive study on the characterization of pheromones has 
demonstrated that they exist as a wide variety of signaling molecules with many chemical 
forms, including proteins and other small molecules (Brennan and Zufall, 2006). While 
they have been classically defined as nonvolatile (unable to disperse as a vapor), recent 
research has again demonstrated that the functional characteristics may be far more 
complex, with nonvolatile and volatile forms now being recognized as pheromones 
(Stowers and Marton, 2005). Two major factors that determine pheromones’ volatility in 
the air and solubility in water are their size and polarity, with the substances often being 
released in sweat and urine (Karlson and Luscher, 1959, Brennan and Zufall, 2006). 
In mammals, the chemosensory structure known as the vomeronasal organ (VNO) 
contains receptors that are specialized to receive and transmit pheromone signals. The 
VNO was first identified in 1813 by Danish anatomist Ludvig Jacobson who believed it 
to be a secretory organ (Doving and Trotier, 1998).  Over the past twenty years extensive 
study has revealed that the VNO is in fact an accessory olfactory organ that is part of the 
larger olfactory system (                    -Marcos, 2003). This system includes the 
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main olfactory epithelium (MOE), the septal organ, and the Grüneberg ganglion, in 
addition to the VNO (Eisthen, 1997,                     -Marcos, 2003). Although 
pheromone detection has been demonstrated in other tissues such as the MOE, in which 
around 5% of olfactory neurons are responsive to pheromones, the VNO is highly 
specialized with the vast majority of the vomeronasal sensory neurons (VSNs) 
responding to pheromones (                    -Marcos, 2003, Oshimoto et al., 2013). 
Detailed structural information on the VNO is now available, and its signal transduction 
mechanisms continue to be elucidated. The critical role it plays in regulating behavior 
through the transduction of pheromones is also well documented (                    -
Marcos, 2003).  
Pheromone signal transduction by the VNO plays an important role in regulating 
the behavior and activity of mammals. The endocrine responses initiated through 
pheromone signaling can have long term effects, while behavioral responses are often 
rapid and transient in nature (Dulac and Torello, 2003). An example of the pheromonal 
regulation of endocrine functions in mice is the modification of the hypothalamic-
pituitary axis upon the chemotransduction of male and female pheromones. When 
exposed to male pheromones a female mouse will experience an increase in luteinizing 
hormone and a decrease in prolactin as regulated by the hypothalamic-pituitary axis, 
while exposure to female pheromones will lead to an  increase in prolactin in other 
female mice (Keverne and de la Riva, 1982, Dulac and Torello, 2003). These changes in 
endocrine function can lead to the onset of puberty or the termination of pregnancy in 
female mice upon detection of male pheromones (known as the Bruce Effect), while the 
detection of female pheromones by female mice can cause a delay in the onset of puberty 
PURINERGIC SIGNALING RECEPTORS IN THE VNO 6 
 
(Bruce, 1959, Bellringer et al., 1980). These pheromone regulated behavioral changes 
initiated by the modification of the hypothalamic-pituitary axis hav  b      m   “  im   
 h  omo    ff c s” (                    -Marcos, 2003).  
Pheromone signaling can also lead to rapid behavior modification in mice (Dulac 
and Torello, 2003). These modifications include the initiation of aggression, copulatory 
behavior, and lordosis (a posture that demonstrates sexual receptivity), among others 
(Dulac and Torello, 2003, Chamero et al., 2012). Removal of the mouse VNO severely 
disrupts reproductive behavior so that mounting and lordosis are not preferentially 
directed towards the opposite sex (Stowers et al., 2002, Samuelsen and Meredith, 2009). 
Trpc2 (transient receptor potential cation channel 2) mutants lose some VNO 
functionality, and along with it aggressive and territorial behaviors (Chamero et al., 
2012). The VNO also plays an important role in eliciting predator based defensive 
behaviors in mice (Stowers et al., 2002, Chamero et al., 2012).  
Despite its powerful influence among many mammals, it is widely accepted that 
humans no longer have a VNO, although we still respond to pheromones through signal 
reception in the MOE (                    -Marcos, 2003, Wang et al., 2007, Chamero 
et al., 2012).  Regardless of the presence or absence of the VNO in humans, it remains an 
important and dynamic organ to study as i    ovi  s “fu   m      i fo m  io  o   h  
o g  i   io       vo u io  of ch mic   commu ic  io ,”  s w     s informing on the 
neural processing of the historically mysterious sexual and social behaviors of animals 
(Chamero et al., 2012).  
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The mouse VNO is a paired tubular structure at the tip of the nose that is encased 
in a bony capsule (                    -Marcos, 2003) (Figure 1). The lumen through 
which substances move separates the non-sensory and sensory epithelia and is connected 
to the nasal cavity by the vomeronasal duct (                    -Marcos, 2003). On 
the side of the non-sensory epithelium a large blood vessel runs the length of the VNO 
lateral to the lumen (Dulac and Torello, 2003). This section of the tissue is also populated 
by connective tissue and glands that underlie the ciliated non-sensory epithelium (Dulac 
and Torello, 2003). The cilium of the non-sensory epithelium beats to help move material 
in and out of the lumen of the VNO.  
 
Figure 1. Sagittal view of a mouse head highlighting the location of the VNO and the 
AOB. Apical and basal VSNs project their axons to the glomeruli of the anterior 
(yellow) or posterior (red) AOB respectively. In turn, the AOB transmits to the bed 
nucleus of the stria terminalis (BST), the bed nucleus of the accessory olfactory tract 
(BAOT), the posteroventral medial amygdala (MePV), and the posteromedial 
cortical amygdala (PMCo). The inset shows a diagram of a coronal section of the 
VNO, showing the crescent-shaped sensory epithelium with the two major layers, 
apical and basal. Reprinted from Trends in Neuroscience, 35(10), Chamero, P., 
Leinders-Zufall, T., & Zufall, F., From genes to social communication: molecular 
sensing by the vomeronasal organ, 597-606, 2012 with permission from Elsevier. 
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Substances arrive in the lumen of the VNO through a mechanism known as the 
vasomotor pump. Meredith et al. (1980) first demonstrated that the blood vessels in the 
vicinity of the hamster VNO serve as a pump that draws chemicals into the lumen. In 
hamsters, this pump appears to be activated in response to any novel stimulus (Meredith, 
1994). Ben-Shaul et al. (2010) found that a similar vasomotor pumping activity also 
occurs in the mouse VNO to draw in potential signaling molecules. This vasomotor 
pumping mechanism not only draws chemicals into the lumen for detection by the VSNs, 
but leads to a release of ATP (Vick and Delay, 2012).  
The crescent-shaped sensory epithelium, or neuroepithelium, of the VNO is 
populated by vomeronasal sensory neurons (VSNs), supporting cells, and basal cells 
(                    -Marcos, 2003) (Figure 2). VSNs are bipolar cells that have a 
single apical dendrite and dendritic knob that reaches to the surface of the lumen and an 
axon that projects to the accessory olfactory bulb (AOB) (Dulac and Torello, 2003, 
Ghiaroni et al., 2003, Chamero et al., 2012). The AOB is positioned on the dorsal 
posterioregion of the olfactory bulb (Figure 1) (Chamero et al., 2012). The dendrites of 
the VSNs end in dendritic knobs with microvilli that contain much of the chemosensory 
machinery of the VNO including the V1R and V2R receptors and Trcp2 (Chamero et al., 
2012). These dendrites are bathed continually in fluid that is secreted from the VNO 
glands at the ventral and dorsal tops of the lumen (Dulac and Torello, 2003). In isolation, 
VSNs are identifiable by their large cell body and clear dendrite.  
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Figure 2. A coronal section of the mouse VNO. The lumen (L), sensory epithelium 
(SE), non-sensory epithelium (NSE), and the blood vessel (BV) are labeled for 
reference. Within the sensory epithelium VSNs with dendrites reaching to the 
luminal surface can be observed. DIC image taken with a 20x lens.  
 
 VSNs are noted to activate at current injections as low as 1 pA, which may help 
account for their high sensitivity to chemical signals (Liman and Corey, 1996, Inamura 
and Kashiwayanagi, 2000). Signal transduction in the VNO is largely dependent on 
receptors in the dendritic knobs of the VNO. Upon activation by pheromones, receptors 
such as V1R (in the apical layer) and V2R (in the basal layer) activate downstream signal 
transduction mechanisms (Berghard et al., 1996, Holy et al., 2000, Ukhanov et al., 2007). 
This includes the production of inositol-1,4,5-triphosphate (IP3) and diacylglycerol 
(DAG) by phospholipase C (PLC) (Krieger et al., 1999, Dulac and Torello, 2003). The 
increase in IP3 leads to a subsequent increase in intracellular Ca
2+
 that is released from 
intracellular stores and influxes from extracellular sources, while DAG activates Trpc2 
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which leads to an influx of Ca
2+
 and Na
+ 
 into the microvilli of the VSNs (Halpern and 
Ma       -Marcos, 2003). The influx of Ca
2+
 can go on to stimulate calcium-activated 
chloride current that amplifies the response of the VSNs (Yang and Delay, 2010, Kim et 
al., 2011). As mentioned earlier, this signal transduction is carried by the axon to the 
AOB, where the release of glutamate serves as the neurotransmitter to transmit the 
information throughout the central nervous system (Dudley and Moss, 1995).  
The VSNs share the neuroepithelium of the VNO with the supporting cells and 
the basal cells. The supporting cells of the VNO are bipolar with cell bodies that lie close 
to the luminal border, with short apical processes that reach the epithelial surface and a 
long basal process that reaches to the basal lamina (Ghiaroni et al., 2003). It is possible 
that supporting cells play a role in chemosensory activity of the VNO (Hassenklover et 
al., 2008). They are notable for possessing voltage-gated ion channels that may play a 
role in maintaining homeostasis of the tissue and regulating the chemical composition of 
the intercellular fluid in a manner which supports the excitability of the VSNs (Ghiaroni 
et al., 2003). The basal cells of the VNO lie along the basal lamina of the 
neuroepithelium, and replace apoptotic VSNs through migration and differentiation 
(Cappello et al., 1999, Giacobini et al., 2000). VSNs are continually undergoing 
apoptosis and being replaced, even in adult animals (Giacobini et al., 2000). This ensures 
rapid tissue repair following damage from the harsh environmental stimuli the VNO 
comes in contact with in order to ensure that the tissues maintains optimum performance 
(Giacobini et al., 2000). 
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Purinergic Signaling 
Purinergic signaling, a form of chemical communication in which a purine, 
commonly adenosine tri-phosphate (ATP), adenosine di-phosphate (ADP), or adenosine, 
serves as a signaling molecule through the excitation of P1 and P2 receptors, has become 
an important area of study as purinergic signaling pathways have been found to be 
widespread and have versatile functionality among mammals (Hegg CC, 2003, 
Abbracchio et al., 2009, Housley et al., 2009).  Purinergic signaling was first identified in 
1972, when it was demonstrated that ATP was a neurotransmitter in the noncholinergic, 
non-adrenergic inhibitory nerves of the guinea- ig’s     i  co i (Burnstock, 1972). 
Widespread acceptance of the hypothesis that purines could serve as signaling molecules 
did not occur until the identification and cloning of purinergic receptors in the 1990s 
(Burnstock, 2009). In the twenty years since, it has been determined that purinergic 
signaling receptors are among the most abundant signaling receptors in mammals, having 
been found in every cell and tissue type examined including nervous tissue (Burnstock 
and Knight, 2004). ATP has been shown to be a transmitter or cotransmitter in nerves 
throughout the peripheral and central nervous system (Abbracchio et al., 2009). It serves 
as a fast excitatory neurotransmitter as well as a long-term modulator of growth and 
development, cell proliferation, and cytotoxicity, making purinergic signaling a critical 
and influential signaling system (Zimmermann, 2006, Burnstock, 2009). 
  There are three classes of purinergic receptors; G-protein coupled P1 adenosine 
receptors, ionotropic P2X receptors, and G-protein coupled P2Y receptors (Burnstock, 
2009).  The adenosine receptors have been further split into four categories, A1, 2A, 2B, 
and 3 (Burnstock, 2009). The ionotropic P2X receptors are designated P2X1-P2X7 
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according to the seven distinct genes that code for the individual subunits of the trimer 
that contains two transmembrane domains and a large extracellular loop (Nicke et al., 
1998, North, 2002, Roberts et al., 2006). They are classic ligand-operated ionotropic 
channels that open upon binding of ATP, with a pore that is permeable to monovalent and 
divalent cations, including Na
+
, K
+
 and Ca
2+
 (Ding and Sachs, 1999, Egan et al., 2006). 
The monomer subtypes can form homomeric or heteromeric receptors, making them a 
versatile form of receptor (Abbracchio et al., 2009).  
 While P2X receptors are activated primarily by ATP, P2Y receptors can be 
activated by ADP,  u i i   5′-  i hos h    (UTP), u i i   5′-diphosphate (UDP), and 
UDP-glucose (Abbracchio et al., 2009). These G-protein coupled receptors have the 
classic seven transmembrane domains and are classified into two distinct P2Y subgroups: 
the P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 subgroup and the P2Y12, P2Y13, and P2Y14 
subgroup (Abbracchio et al., 2006). The first subgroup consisting of P2Y1, P2Y2, P2Y4, 
P2Y6, and P2Y11 typically couples with the G-protein Gq/G11 to activate PLC, leading to 
the release of IP3 and the subsequent release of intracellular Ca
2+
 from the endoplasmic 
reticulum (Abbracchio et al., 2009). The second subgroup consisting of P2Y12, P2Y13, 
and P2Y14 couples with G-protein Gi/o, which inhibits adenylyl cyclase and subsequently 
modulates ion channel activity (Abbracchio et al., 2009). These purinergic receptors have 
been extensively reviewed in (Abbracchio et al., 2009) and (Burnstock, 2009).  
Purinergic Signaling in the VNO 
 Recently the role of purinergic signaling in the VNO has been studied in the lab 
of Dr. Rona Delay through the use of electrophysiology, with results suggesting that 
purinergic receptors play important functional roles in the VSNs. Purinergic signaling in 
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the MOE has been more extensively reported in the literature. P2X and P2Y receptors are 
expressed in the sensory epithelium of the mouse MOE, which upon reception of ATP 
reduce the response of the olfactory sensory neurons (OSNs) while also increasing 
intracellular [Ca
2+
] (Hegg CC, 2003).  The ATP that serves as the signaling molecule in 
this pathway is released upon exposure of the OSNs to high concentrations of odorants, 
and induces basal progenitor cells to differentiate into OSNs to replace dead and dying 
neurons (Hegg and Lucero, 2006, Hassenklöver et al., 2009). This suggests that in the 
MOE purinergic receptors play a neuroprotective and neuroregenerative role by 
preventing OSN toxicity and supporting differentiation.  
However, the role of purinergic signaling in the VNO appears to be more varied. 
Vick and Delay (2012) demonstrated that P2X receptors on isolated VSNs are activated 
by ATP and elicited an inward current as well as a concentration-dependent increase in 
intracellular [Ca
2+
](Figure 3). Vick and Delay (2012) also demonstrated that ATP 
increased the response of VSNs to dilute urine.  The study concluded that the release of 
ATP upon mechanical stimulation of the VNO such as during activity of the vasomotor 
pump led to P2X activation which may help regulate the chemosensory activity of the 
organ (Vick and Delay, 2012). The release of purine nucleotides in a mechanosensative 
manner has been well documented in many other tissues, including the retina, urinary 
bladder, kidney nephron, epithelium of the lung, and the cochlea (Homolya et al., 2000, 
Newman, 2001, Zhao et al., 2005, Sipos et al., 2009, Chen et al., 2010). While Vick and 
Delay (2012) found that P2X receptor activation led to an increase in [Ca
2+
]i and an 
inward current, the activation of P2Y receptors did not elicit a similar response. However, 
the possibility remained that these purinergic receptors were present in the organ, and 
PURINERGIC SIGNALING RECEPTORS IN THE VNO 14 
 
performing a yet unrecognized function. This hypothesis was supported by recent 
unpublished data from Vick and colleagues that indicated a functional role for P2Y in 
enabling persistent firing of VSNs (Figure 4).  
 
Figure 3. Electrophysiological data from isolated VSNs demonstrating the role of 
P2X receptors in generating the inward current elicited by ATP. (A) The partial 
block of the inward current by PPADS indicated the P2X receptor is responsible for 
the generation of the current. The normalized inward currents for each VSN tested 
for this response can be seen in (B). (C) The block of the inward current with TNP-
ATP again indicated that the P2X receptor is responsible. The normalized inward 
currents for each VSN tested are plotted in (D). (E) RT-PCR demonstrated the gene 
expression of P2X1 receptors (382 bp) and P2X3 receptors (252 bp) in the VNO. 
L = ladder, + = experimental groups, − = control groups.  Reprinted with permission 
from Neuroscience, 220, Vick J.S. and Delay R. J., ATP excites mouse vomeronasal 
sensory neurons through activation of P2X receptors, 341-350, 2012.  
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Figure 4.  The P2Y1 agonist ADP increased spike frequency in isolated VSNs at 
relatively depolarized current injections without altering other characteristics of the 
action potential.  (A) The increase of spike frequency upon the application of ADP 
can be clearly seen relative to baseline. (B) A quantification of the spike frequency 
from the VSN in (A) revealed a reversible stabilization of the maximal rate of firing 
at higher current injections. (C) The difference in the average percentage change in 
spike frequency of control and ADP was statistically significant at 18 to 20pA of 
current injection. (D) The schematic used to analyze each action potential’s 
amplitude, latency, halfwidth, and threshold voltage with a custom made script 
written in MatLab by Roman Popov. (E)-(H) The difference in the average 
percentage change in latencies to first spike, amplitudes, halfwidths, and the 
thresholds of the control and ADP were not statistically significant. Figure reprinted 
with permission from Jonathan Vick.  
 
Working from this data, the study herein aimed to continue the exploration of 
purinergic receptors in the VNO by identifying gene expression of P2Y receptors in the 
tissue and using methods of immunohistochemistry and immunocytochemistry to 
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determine the immunolocalization of selected common P2Y and P2X receptors. 
Immunohistochemistry in the literature has demonstrated that subsets of both receptors 
have immunoreactivity with the VNO, but no immunocytochemistry has confirmed in 
what cell types the expression occurs (Gayle and Burnstock, 2005). We hypothesized that 
P2X and P2Y receptors would demonstrate gene expression in the VNO with 
immunolocalization to the sensory epithelium, where ATP release via activity of the 
vasomotor pump would activate the purinergic receptors and lead to subsequent 
modulation of the VSN response. The immunolocalization and activity of this pathway in 
the VNO would implicate purinergic signaling in the regulation of mammalian social and 
sexual behaviors.  
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MATERIALS AND METHODS 
VNO Dissection 
All experiments were performed with C57 BL/6 and BALB/C mice raised and 
 u h  i    i   cco    c  wi h  h  U iv  si y of V  mo  ’s I s i u io    A im   C     nd 
Use Committee under IACUC protocol 07-094. Euthanasia was accomplished through 
CO2 asphyxiation followed by cervical dislocation. After the animal was sacrificed the 
VNO was immediately removed through dissection. The head was removed from the 
body, cut bilaterally, and the VNO in the bony casing was extracted. The bony casing 
was then removed in the presence of enzyme free dissociation solution (in mM: 140 
NaCl, 10 HEPES, 10 Glucose, 5 KCl, 2 EDTA, pH. 7.4).  
Reverse Transcription Polymerase Chain Reaction 
To identify gene expression of selected P2Y receptors in the VNO reverse 
transcription polymerase chain reaction (RT-PCR) was performed using primers for 
P2Y1, P2Y2, P2Y4, and P2Y6 receptors. Primers were obtained from Integrated DNA 
Technologies with sequences from del Ray et al. (2006) (Table 1).  Total RNA was 
isolated and purified from the VNO using Qiagen’s RN  sy Mini Kit according to 
m  uf c u   ’s i s  uc io . The purity of the isolated RNA was tested using a NanoDrop 
Spectrophotometer courtesy of the Vermont Genetics Network Proteomics Facility.  
cDNA was synthesized with 200U SuperScript III Reverse Transcriptase 
(Invitrogen) and 2.5 μM random hexamers (Applied Biosystems) with 2 μg of total RNA 
in a volume of 20 μL. RNaseOUT (Invitrogen) was added to the reactions to prevent 
degradation of the RNA by inhibiting ribonuclease. A negative control was performed by 
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omitting SuperScript III Reverse Transcriptase in order to ensure that the PCR products 
were produced from the cDNA rather than contaminants. The following conditions were 
followed for cDNA synthesis: i. 25° C for 5 minutes, ii. 50° C for 30 minutes, iii. 55° C 
for 30 minutes, iv. 70° C for 15 minutes, v. final hold at 4 ° C.  
PCR was performed using 1 μL cDNA, 12.5 pmol forward and reverse primers, 
2.5 mM MgCl2 (Invitrogen), 200 μM dNTPs (New England BioLabs), 10x PCR reaction 
buffer (Invitrogen), and 1.25U Taq polymerase (Invitrogen) in a final volume of 25 μL. 
The following conditions were followed for PCR: i. serial heating at 94° C for 5 minutes; 
ii. amplification over 35 cycles at 94° C for 30 seconds and 72° C for 30 seconds; iii. 
final hold at 4 °C.  
The amplified products were resolved with gel electrophoresis with a 1% agarose 
gel run at 130 mV for 30-60 minutes. The gel was stained with ethidium bromide for 30-
60 minutes and observed and photographed using a UV light box. PCR products were cut 
out and purified from the agarose gels using Omega Bio-T k’s G   Ex   c io  Ki  
according to manufactu   ’s i s  uc io s     s qu  c   with the assistance of the 
Vermont Genetics Network (http://www.vermontcancer.org/). Sequences were checked 
with the basic local alignment search tool (BLAST) to confirm the product was that of 
the desired purinergic receptor.  
Immunohistochemistry 
 Immunohistochemistry was performed using antibodies for P2Y1, P2Y2, and P2X1 
receptors as specified in Table 2. The dissected VNO was fixed in 4% paraformaldehyde 
fixative in 0.1 M phosphate buffer solution for 1 hour and then rinsed twice in 0.1 M 
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phosphate buffer. All rinses were accomplished by moving the tissue between the wells 
of a 6-well plate. The VNO was then embedded in 15% gelatin in 0.1 M phosphate buffer 
and returned to the 4% paraformaldehyde fixative for 1 hour. The tissue was then washed 
6 times for 10 minutes each in 0.1 M phosphate buffer. In order to confer cryoprotection 
the tissue was run through a graded sucrose solution consisting of 0.5 M, 1 M, 1.5 M, and 
2 M sucrose in 0.1 M phosphate buffer solution. The VNO was sectioned with a Microm 
HM505E cryostat at ~ –26° C to a thickness of 20 μm. Sections were placed in phosphate 
buffered saline (PBS). 
 Selected sections were then transferred to wells of a 6-well plate, 4 sections to 
each well, and washed in a preincubation buffer consisting of 6.5 % normal goat serum in 
0.1 M phosphate buffer with 10% Triton-x-100 (Acros Organics) for 1 hour with mixing 
at room temperature. The sections were then incubated in primary antibody for 24 hours 
at room temperature with mixing. All antibodies were diluted in preincubation buffer. 
The P2Y1 primary antibody was diluted to a concentration of 1:100, the P2Y2 primary 
antibody was diluted to a concentration of 1:500, and the P2X1 primary antibody was 
diluted to a concentration of 1:500, as detailed in Table 2. A negative control was 
performed by incubating without primary antibody.  
After primary incubation the sections were washed with PBS 6 times for 10 
minutes each. They were then incubated with secondary goat anti-rabbit TRITC 
conjugated antibody (Invitrogen) at a concentration of 1:1000 for 1 hour. The sections 
were incubated in the dark at 4°C. Sections were washed with PBS and mounted with 
Flouromount-G (Southern Biotek). Slides were stored in the dark at room temperature for 
24 hours to allow the Flouromount to harden and then stored in the dark at 4
0 
C. 
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 Sections were imaged with a Zeiss Axioskop2 microscope fitted with a 
Photometrics CoolSnap EZ camera with NIS Elements used for image capture. Images 
were obtained using 20x and 40x objectives, with care being taken to image control 
sections with the same exposure as the experimental sections. All images were saved as 
TIFF files and processed using the image processing package FIJI, also known as Image 
J. Edited images were then saved as both TIFF files and JPEG files and a figure was 
made using Adobe Photoshop.  
Immunocytochemistry 
Immunocytochemistry was performed using antibodies for P2Y1 and P2Y2 
receptors as specified in Table 2.  Isolated cells were obtained through either a 
collagenase or papain digestion. The collagenase digestion was performed by 
mechanically dissecting the VNO for 10 minutes in dissociation solution supplemented 
with 1 mg/ml collagenase (Sigma) and 40 μL trypsin (Life Technologies). The digestion 
solution was rotated for 1 hour before being transferred to a 1 mL eppendorf tube and 
centrifuged at 4.8 RPM for 1 minute. The resulting cell pellet was then resuspended with 
Ri g  ’s so u io  (i  m : 138 N C , 5 KC , 10  EPES, 2 gC 2, 2 CaCl2, 10 glucose; 
pH 7.4) supplemented with 1 mg/mL DNase (Sigma) and rotated for an additional 20 
minutes. The resulting cell suspension was transferred to a test tube and gently triturated 
for 2-3 minutes. The papain digestion was performed by placing the VNO in dissociation 
solution supplemented with 10mg/mL papain (Calbiochem) for 10 minutes of mechanical 
dissection. The solution was then transferred to a test tube containing Ri g  ’s so u io  
supplemented with ≈10 μg/mL   u    i  (USB) to inhibit papain and was gently 
triturated for 2-3 minutes.  
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The resulting cell suspension from either digestion was plated on round glass 
cover slips coated with concanavalin A (Calbiochem). The cell suspension was allowed 
to settle for 30 minutes before being fixed with 4% paraformaldehyde fixative in 0.1 M 
phosphate buffer for 15 minutes. The cover slips were then rinsed with 0.1 M phosphate 
buffer. Once plated, the cells were washed with preincubation buffer for 30 minutes.  The 
cells were then incubated with primary antibody for 24 hours at 4° C. P2Y1 and P2Y2 
receptor primary antibodies were diluted in preincubation buffer to a concentration of 
1:500 (Table 2). A negative control was performed by incubating without primary 
antibody. After primary incubation the cells were washed with PBS 3 times for 5 minutes 
each. Secondary incubation was then performed in the dark at 4° C with a secondary goat 
anti-rabbit TRITC conjugated antibody (Invitrogen) at a dilution of 1:1000 for 1 hour. 
The cells were then washed with PBS 2 times for 5 minutes each. A final wash in 
distilled water was then performed before the cover slips were mounted with 
Flouromount-G to avoid crystallization. The slides were stored in the dark at room 
temperature for 24 hours to allow the Flouromount to harden before being stored at 4°C.  
Isolated VSNs were imaged with a Keyence BZ-9000 Fluorescence microscope 
with the associated BZ-II Analyzer. VSNs were identified by morphological 
characteristics using phase contrast microscopy. Images were obtained using a 40x 
objective with 68x magnification, with care being taken to image control slides with the 
same exposure as the experimental slides. All images were saved as TIFF files and a 
figure was made with Adobe Photoshop. Slide screening was also performed at 40x 
magnification, with 20-30 VSNs being observed for each treatment. 
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Name Primer Sequence Approximate 
Product Size (bp) 
P2Y1 Forward 5'- ATC AGC GCA CAC AGG TAC AG -3' 200  
 Reverse 5'- AAT CAT TGG ACG TGG TGT CA -3’  
P2Y2 Forward 5'- CAG GCC TGT GCA TAT GTG AG -3' 200 
 Reverse 5'- GGC AAC AGC ACG TAC TTG AA -3'  
P2Y4 Forward 5'- CCA CAT CAG GGG GAA CTA AG -3' 200 
 Reverse 5'- CAA GGA GTC TGC ACT GGT CA -3'  
P2Y6 Forward 5'- AAC CTG CCT TGA AAA CAA CG -3' 200 
 Reverse 5'- TTA GCA GCA GTC GCT TGA AA -3'  
 
Table 1. Primers for RT-PCR and their product sizes in base pairs (bp). 
Antigen Host Immunohistochemistry 
Dilution 
Immunocytochemistry 
Dilution 
Source 
Primary Antibody     
     P2Y1 Receptor Rabbit 1:100 1:500 Alomone Labs 
     P2Y2 Receptor Rabbit 1:500 1:500 Alomone Labs 
     P2X1 Receptor Rabbit 1:500 N/A Alomone Labs 
Secondary Antibody     
     Goat Anti-Rabbit 
     TRITC Antibody 
Goat 1:1000 1:1000 Invitrogen 
 
Table 2. List of antibodies for immunohistochemistry and immunocytochemistry. 
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RESULTS 
P2Y1, P2Y2, and P2Y6 receptor transcripts are present in the mouse VNO 
  We performed RT-PCR in order to determine which P2Y receptor subtypes have 
gene expression in the mouse VNO using primers for P2Y1, P2Y2, P2Y4, and P2Y6 
receptors. Gene expression of P2Y1, P2Y2, and P2Y6 receptors was detected (Figure 5). 
We observed the product band for each purinergic receptor at the expected locale of 200 
base pairs. There was no gene expression of the P2Y4 receptor detected (data not shown). 
Gene expression was confirmed with sequencing by the Vermont Genetics Network and a 
basic local alignment search (BLAST).  The BLAST results confirmed sequencing with 
98%-100% matching identities (Supplemental Figure 1-3).  
While the RT-PCR clearly indicated gene expression of the P2Y receptors, there 
were two anomalies. The first is the band which can be observed at the bottom of the 
P2Y1 gel (Figure 5). This does not indicate gene expression, but is rather a common by-
product of the PCR process known as a primer dimer. The other occurrence is the second 
band present around 450 base pairs in the P2Y2 gel (Figure 5). This band was sequenced 
and found to be mucin 5 subtype B, a gene that encodes for a mucosal protein unrelated 
to purinergic signaling receptors. As the product band in the same gel at 200 base pairs 
was sequenced and confirmed to be of the P2Y2 receptor, the presence of the mucin 5 
subtype B band did not interfere with the results. When taken in conjunction with the 
results of the RT-PCR performed by Vick and Delay (2012), there is now supporting 
evidence for gene expression of P2X1, P2X3, P2Y1, P2Y2, and P2Y6 receptors in the 
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mouse VNO.  These results support the hypothesis that there is purinergic receptor 
expression in the mouse VNO.  
Localization of purinergic receptors to the sensory epithelium of the VNO  
The sensory epithelium of the VNO showed strong immunoreactivity to the P2Y1, 
P2Y2, and P2X1 receptor antibodies with immunohistochemistry (Figure 6). The P2Y1 
receptor antibody exhibited immunoreactivity throughout the sensory epithelium, with 
particularly intense staining at the apical edge and within the supporting cell layer. The 
dendrites and the dendritic knob region of the sensory epithelium appeared to be 
particularly immunoreactive. The cell bodies of the VSNs were also clearly 
immunoreactive. However, as indicated by the dotted appearance of the staining 
throughout the sensory epithelium where the cell bodies of the VSNs are located, the 
P2Y1 receptor antibody did not stain all VSNs but rather demonstrated selectivity. The 
lack of immunoreactivity in the negative control for the P2Y1 receptor antibody 
suggested that the staining observed in the sensory epithelium was specific.  
The P2Y2 receptor antibody exhibited more uniform immunoreactivity with 
strong staining throughout the sensory epithelium of the VNO (Figure 6). The dendritic 
knobs at the apical edge again showed the most intense labeling, with the VSN cell 
bodies showing strong and consistent staining throughout the tissue sections. The basal 
lamina region also showed significant immunoreactivity to the P2Y2 receptor antibody. 
Of particular interest was the staining pattern in the supporting cell layer of the sensory 
epithelium which displayed a unique pattern of speckling upon close inspection. The 
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negative control for the P2Y2 receptor antibody suggested that the staining observed in 
the sensory epithelium was specific. 
The immunohistochemistry for the P2X1 receptor antibody also displayed 
immunoreactivity throughout the sensory epithelium (Figure 6). There was staining 
present throughout the cell bodies of the VSNs, while the dendritic regions of the 
epithelium again demonstrated the most intense labeling. However, there was minimal 
immunoreactivity in the basal lamina and supporting cell layers. The negative control for 
the P2Y2 receptor antibody again indicated that staining observed in the sensory 
epithelium was specific. 
Localization of purinergic receptors to the non-sensory epithelium of the VNO 
 In addition to the immunoreactivity that was present throughout the sensory 
epithelium, there was also immunoreactivity for the P2Y1, P2Y2, and P2X1 receptor 
antibodies present on the ciliated non-sensory epithelium (Figure 6). The 
immunoreactivity was uniform throughout the epithelium for all three receptor 
antibodies, and the negative controls indicated that the staining was specific. It is 
probable that purinergic receptors, as has been demonstrated by their ubiquitous presence 
in every cell and tissue type so far examined, are also present in that non-sensory 
epithelium of the VNO.  
Localization of purinergic receptors to the glandular tissue of the VNO 
 Similar to the staining observed on the non-sensory epithelium, there was strong 
immunoreactivity for the P2Y1, P2Y2, and P2X1 receptor antibodies in the glandular 
tissue of the VNO (Figure 6). However, the negative controls for the P2Y1, P2Y2, and 
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P2X1 receptor antibodies indicate that the staining may be largely nonspecific.  
Localization of purinergic receptors to the VSNs 
Immunocytochemisty was performed with P2Y1 and P2Y2 receptor antibodies 
based on antibody availability. Twenty to thirty isolated VSNs were identified 
morphologically by a rounded cell body, elongated dendrite, and a dendritic knob for 
each antibody tested and representative isolated VSNs were imaged (Figure 7). Strong 
immunoreactivity was noted in approximately 60%-70% of the VSNs observed. 
Immunoreactivity was observed in the cell body, dendritic knob, and dendrite for both the 
P2Y2 and P2Y1 receptor antibodies. The negative controls show a lack of 
immunoreactivity. 
 
 
 
Figure 5. RT-PCR demonstrating gene expression of P2Y1, P2Y2, and P2Y6 in the mouse 
VNO. The expected product size for all primers was approximately 200 base pairs 
(bp). L = ladder, + = experimental groups, − = control groups. 
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Figure 6. Immunohistochemisty demonstrating the immunoreactivity to P2Y1, P2Y2, 
and P2X1 receptor antibodies in the mouse VNO.  Images were obtained at 20x and 
40x magnification with a TRITC filter. Negative controls are also shown.  
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Figure 7. Immunocytochemisty demonstrating the immunoreactivity to P2Y1 and 
P2Y2 receptor antibodies in isolated VSNs. VSNs were identified by morphology. 
Images were obtained at 68x magnification with phase contrast (PC) and a TRITC 
filter. Negative controls are also shown.   
 
 
 
 
 
 
 
 
 
 
 
 
PURINERGIC SIGNALING RECEPTORS IN THE VNO 29 
 
DISCUSSION 
My results strongly support the hypothesis that there are purinergic receptors 
demonstrating gene expression and immunolocalization in the mouse VNO. The 
localization of purinergic receptors to the sensory epithelium of the VNO suggests a role 
for purinergic signaling that is supported by previous electrophysiological data (Vick and 
Delay, 2012). The results of the RT-PCR have supplemented the list of purinergic 
receptors that have been demonstrated to have gene expression in the VNO of mice. 
While P2X1 and P2X3 receptors were shown to have gene expression in the VNO by 
Vick and Delay (2012), this study was able to add P2Y1, P2Y2 and P2Y6 to that list. This 
is the first RT-PCR evidence that P2Y receptors are present in the VNO, supporting our 
hypothesis and suggesting the possibility that there are a wide range of purinergic 
receptors present in the organ.  To the best of our knowledge, this is also the first study to 
demonstrate the immunolocalization of purinergic receptors to the VSNs, with the 
localization of P2Y receptors to the cell bodies and dendritic regions.  The 
immunolocalization of the purinergic receptors to the VSNs and throughout the tissue of 
the VNO indicates that purinergic receptors may play a wide range of functional roles in 
the organ, including modulation of pheromone sensory detection and transduction, 
motilary function, mucocous secretion, and the maintenance of homeostasis.  
The immunolocalization of the purinergic receptors P2Y1, P2Y2, and P2X1 to the 
sensory epithelium of the VNO supports the hypothesis that purinergic signaling 
receptors in the VNO play a role in the chemosensory activity of the organ. The 
immunocytochemistry results that demonstrate immunolocalization of P2Y1 and P2Y2 
receptors to the VSNs further support this hypothesis. The results closely match what 
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Gale and Burnstock (2005) observed, with immunoreactivity of the VNO to the P2Y1 and 
P2Y2 receptor antibody. They saw particularly strong staining in the luminal face of the 
VNO as we did, as well as staining that extended through the entire epithelium. The 
immunolocalization of the purinergic signaling receptors to the sensory epithelium and 
VSNs strongly suggests that they play a role in signal transduction. Interestingly, the 
receptors are seen to be on the cell body as well as the dendrite, while the V1R/V2R 
receptors are localized to the dendritic knob. This suggests that the purinergic receptors 
may be playing a role in maintaining the homeostasis of the cell through activity in the 
cell body, which modulates it excitability and responsiveness to pheromone signaling. As 
hypothesized by Vick and Delay (2012), it is also possible that the purinergic receptors, 
particularly those immunolocalized to the dendritic knob of the VSNs, respond to 
nucleotides released upon activation of the vasomotor pump that draws material into the 
lumen of the VNO. The activation of the purinergic receptors may prime the VSNs for 
pheromone signal transduction, or perhaps work to maintain optimal operating conditions 
for VSN activity upon the reception of material in the lumen of the VNO by way of the 
vasomotor pump. Further study is necessary to fully understand this effect.  
The immunolocalization of the purinergic receptors to the nonsensory epithelium, 
particularly the ciliated epithelium and the glandular epithelium, illustrates the multiple 
functional roles of purinergic receptors. These results suggest that in the VNO alone they 
may play multiple functional roles, aiding in the chemosensory activity of the organ both 
through movement of the signaling molecules into and through the lumen and in the 
VSNs themselves, modulating and maintaining signal transduction. Gayle and Burnstock 
(2005) also observed that the purinergic receptor immunoreactivity was not limited to the 
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sensory epithelia. The presence of immunoreactivity of P2Y1, P2Y2, and P2X1 in the 
ciliated epithelium of the VNO suggests that the purinergic receptor may play a role in 
the locomotion of cilia and the movement of signaling molecules into and around the 
lumen of the organ, in order to ensure contact with the sensory epithelium. An increase in 
ciliary activity was noted in frog epithelium upon contract with increasing concentrations 
of ATP (Ovadyahu et al., 1988). Similarly, Winters et al. (2008) found that ciliary beat 
frequency was increased upon activation of P2Y2 receptors in the mouse trachea. When 
the vasomotor pump is activated and ATP is released, it is possible that activation of the 
purinergic receptors on the ciliated epithelia results in increased activity in a similar 
manner. This would conserve energy by ensuring that the ciliated epithelium is only 
active when needed to move fresh material into and around the lumen of the VNO. 
The expression of purinergic receptor antibodies in the glandular tissue of the 
VNO may also be significant. Not only does it further highlight the extreme diversity of 
function that the purinergic receptors encompass, but it is also suggests that purinergic 
signaling in the glandular tissue has an impact on the activity of the VNO. The glandular 
tissue of the VNO secretes mucous that helps move the pheromone signaling molecules 
throughout the lumen and lubricates the epithelia (                    -Marcos, 2003). 
However, a study of the rat VNO hypothesized that the glandular tissue of the VNO 
could also be modulating sensory responses through endocrine functions (Lee et al., 
2008).  Lee et al. (2008) found signaling proteins and mechanisms in the glandular tissues 
of the VNO, suggesting that the glandular tissues may modulate the chemosensory 
activity of the VNO by altering the responsiveness of the VSNs in correlation with 
hormonal status. It is possible, although much study would need to be performed to 
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address the hypothesis, that the purinergic receptors immunolocalized to the glandular 
tissue of the VNO may play a role in the chemosensory activity of the tissue beyond 
excretion of mucus to lubricate the epithelia and transmission of pheromones.    
Additionally, the immunoreactivity of the P2Y receptor antibodies to the 
supporting cell layer of the VNO is indicative that the supporting cells are expressing 
purinergic signaling receptors in addition to the VSNs. In many other areas of the 
nervous system, glial and supporting cells have been demonstrated to play an active role 
in purinergic signaling pathways, expressing many of the receptors (Neary et al., 1996, 
Brass et al., 2012, Vitanova and Kupenova, 2014). In the MOE, supporting cells express 
purinergic receptors that upon activation by ATP leads to Ca
2+
 responses and gap 
junction opening (Vogalis et al., 2005, Czesnik et al., 2006). It has already been 
suggested that the supporting cells of the vomeronasal organ play an important role in the 
chemosensory activity of the VNO by potentially mopping-up excess K
+
 and Na
+  
in the 
lumen and sensory epithelia in order to maintain homeostasis and optimal VSN activity 
(Ghiaroni et al., 2003). With this evidence of purinergic receptors in the area of the  
supporting cells, there may be even more layers of complexity to the activity of the 
supporting cells that should be further explored, as it is possible that they play an 
important role in modulating the chemosensory activity of the VNO.  
However, the presence of purinergic receptors in the VNO suggests functional 
roles that may go far beyond modulation of chemosensory transduction. Purinergic 
receptors have been demonstrated to exert multiple functional roles in sensory systems, 
including controlling the development, remodeling, and regeneration of the systems 
(Zimmermann, 2006). In other areas of the nervous system purinergic receptors play a 
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role in trophic actions, regulating neuronal survival, growth, and apoptosis (Neary et al., 
1996).  ATP released from injured cells in the MOE leads to activation of P2 receptors on 
the sensory neurons, supporting cells, and basal cells, initiating protective responses and 
stimulating progenitor basal cell proliferation to regenerate damaged tissue (Housley et 
al., 2009). In other areas of the nervous system, it has been demonstrated that when nerve 
growth factor and P2Y receptors are co-activated, neuronal survival and growth is up-
regulated (Arthur et al., 2006). In another study, activation of P2Y1 and P2Y2 receptors 
resulted in an increase of progenitor cell proliferation, leading to neurogenesis and 
remodeling (Zimmermann, 2006). It is possible that the P2Y receptors that have been 
identified in the VNO may be playing a role in the growth, development, and 
regeneration of the organ. Furthermore, the immunolocalization of P2Y1 and P2Y2 
receptors in the VSNs would place them in an ideal position for this activity.   
These results can serve as the basis for a wide range of future study on the topic 
of purinergic signaling in the VNO.  To continue the line of inquiry it will be important to 
further identify P2 as well as P1 receptors that are present in the VNO. This study 
explored a few common purinergic signaling receptors, leaving many others to be 
investigated. The acquisition of specific antibodies to explore the immunolocalization of 
these receptors will be important to this process. In this study it was not possible to 
successfully explore the immunolocalization of the P2X3 receptor due to the nonspecific 
nature of the antibodies available. This was unfortunate as previous studies have 
indicated strong immunoreactivity of P2X3 in the mouse VNO (Gayle and Burnstock, 
2005). Identifying and acquiring specific antibodies will be crucial to the further study of 
immunolocalization of purinergic receptors.  With these antibodies at hand, 
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colocalization experiments with other cellular molecules such as Ga/o will be possible to 
determine what signaling mechanisms the purinergic receptors are interacting with. In 
conclusion, while there is still much to be explored on this topic, this study has 
demonstrated that there are purinergic signaling receptors present in the mouse VNO. 
The immunolocalization of these receptors strongly supports the hypothesis that the 
receptors are playing an active role in the modulation of the chemosensory activity of the 
organ, and therein playing a role in the regulation of social and sexual behavior of the 
mammal.  
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